Prevention of Hand Eczema Among Workers in the Fishing Industry in Greenland: an Intervention Study
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Bispebjerg Hospital
- Enrollment
- 70
- Locations
- 4
- Primary Endpoint
- Change from baseline in knowledge of hand eczema at 3 months
Study Overview
Brief Summary
This study aims to investigate the effect of a prevention programme on hand eczema among workers in the Greenlandic fishing industry. This is a non-randomised clinical trial including employees at four of Royal Greenland's fish processing facilities in Greenland.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Prevention
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Employee in Royal Greenland, a state-owned company and one of the largest seafood enterprises in the world
- •Written informed consent
Exclusion Criteria
- •Age below 18 years
- •Inability to understand the Greenlandic, Danish or English language
- •Pregnancy
- •Other chronic skin diseases on the hands
- •Receiving immunomodulatory therapies
Outcomes
Primary Outcomes
Change from baseline in knowledge of hand eczema at 3 months
Time Frame: From enrollment to the end of intervention at 12 weeks
Knowledge of hand eczema measured by a self-reported questionnaire
Change from baseline in clinical severity of hand eczema at 3 months
Time Frame: From enrollment to the end of intervention at 12 weeks
Clinical severity of hand eczema measured by Hand Eczema Severity Index (HECSI). The HECSI score ranges from 0 to 360, with higher scores reflecting greater disease severity.
Secondary Outcomes
- Change from baseline in patient-reported quality of life at 3 months(From enrollment to the end of intervention at 12 weeks)
- Change from baseline in Patient Global Assessment of Disease Severity (PaGA) at 3 months(From enrollment to the end of intervention at 12 weeks)
- Change from baseline in the number of self-reported days with absence from work due to hand eczema at 3 months(From enrollment to the end of intervention at 12 weeks)
- Change from baseline in the number of participants being forced to change their job due to hand eczema at 3 months(From enrollment to the end of intervention at 12 weeks)
- Change from baseline in the availability of protective equipment at 3 months(From enrollment to the end of intervention at 12 weeks)
Investigators
Mathilde Tuborg Andersen, MD
Principal Investigator
Bispebjerg Hospital